EN DE
Watch PEE CEE COSMA SOPE LTD. for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

PEE CEE COSMA SOPE LTD. (PCCOSMA) fair value: what the stock is really worth

As of Nov 19, 2026: fair value (intrinsic value) of PEE CEE COSMA SOPE LTD. stock ₹619.81, price ₹436.75, upside +41.9%, quality 66 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive IN · ISIN INE417E01010

PC PEE CEE COSMA SOPE LTD. logo Broad data Nov 16, 2026

PEE CEE COSMA SOPE LTD.

PCCOSMA · BSE

Cheap (30% below fair value) and solid company, but price moving sideways: meets 2 of 3 rules.

Follow free in the weekly email
Fair value ₹619.81 · Undervalued 
Quality 66/100 
Healthy Growth (revenue 5y +13.9 %/yr in INR) 
Low debt 
Generates free cash flow 
0.7% dividend yield · Well covered
Ranks above peers (10/14) 
Broad data 
Revenue last quarter +23% vs. a year ago. 
Price moving sideways (no uptrend) 
Thin margins · 5.2% net margin (TTM) 
Moderate moat 54/100 · thin data
Watch PEE CEE COSMA SOPE LTD. for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹893.66 ₹87.99 Fair Value ₹619.81 May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range ₹87.99 – ₹893.66 · fair‑value band ₹464.33 – ₹775.29 · the ₹436.75 price screens below the ₹619.81 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow PEE CEE COSMA SOPE in your weekly email

Every Wednesday you see whether PEE CEE COSMA SOPE is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Pee Cee Cosma Sope Limited manufactures and sells laundry soap, and detergent powder and cake in India. It also offers cleaning preparation, soap chips, toiletry, and other products. The company sells its products under the Doctor brand name.

Show moreShow less

Pee Cee Cosma Sope Limited was founded in 1947 and is based in Agra, India.

Stock analysis

PEE CEE COSMA SOPE LTD. (PCCOSMA) currently trades at ₹436.75, while our model-based Fair Value estimate is ₹619.81, implying the stock looks roughly 30% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of ₹812.81 per share, and 18 of the 26 models we run sit above the ₹436.75 price.

Bear case: the Asset-Based group reads lowest at ₹119.90, and 8 of the 26 models stay below the price. Data coverage for this calculation is high.

Scenario range: ₹464.33 (bear) to ₹775.29 (bull), the price of ₹436.75 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 66/100 (solid quality), in the Consumer Defensive sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

PEE CEE COSMA SOPE LTD. reported revenue of ₹1.6B in FY2026 versus ₹927M in FY2022, a compound +14.3%/yr. Reported net income was ₹83.3M in FY2026, compounding +49.1%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.

Key figures

Market cap ₹1.2B (≈ $12.4M) Micro · P/E ratio 13.3 · P/S ratio 0.69 · EPS (TTM) ₹32.80 · Dividend yield 0.7% · Net margin 5.2% · Return on equity 15.9% · Return on assets (EBIT) 15.7% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 54 out of 100 (low confidence).

What moves the price

The share trades about 13% below its 52-week high and 49% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −29% fair-value upside, at 42%, PCCOSMA screens cheaper than that median.

Fair Value models

Bear ₹464.33 Fair Value ₹619.81 Bull ₹775.29
Price ₹436.75 · Upside +41.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹19.10 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ₹577.83 ₹941.67 ₹1,494 79
Growth DCF ₹570.77 ₹894.11 ₹1,357 78
Owner Earnings ₹583.22 ₹950.56 ₹1,508 75
All 26 models by family
DCF Models
FCF DCF ₹577.83 ₹941.67 ₹1,494 79
Owner Earnings ₹583.22 ₹950.56 ₹1,508 75
5Y Revenue Exit ₹456.13 ₹733.29 ₹1,099 72
5Y EBITDA Exit ₹490.75 ₹803.79 ₹1,187 74
5Y P/E Exit ₹507.42 ₹837.73 ₹1,207 70
10Y Revenue Exit ₹485.46 ₹749.06 ₹1,134 66
10Y EBITDA Exit ₹517.33 ₹796.25 ₹1,200 68
10Y P/E Exit ₹527.45 ₹818.97 ₹1,216 63
Earnings-Based
Graham-Dodd ₹213.97 ₹954.40 ₹1,308 64
Lynch FV ₹265.44 ₹379.21 ₹492.97 61
PEG = 1.0 ₹265.44 ₹379.21 ₹492.97 57
EPV ₹319.05 ₹360.99 ₹396.05 74
Dividend Discount
Gordon GGM ₹23.58 ₹42.86 ₹59.44 68
DDM Multi-Stage ₹23.58 ₹38.97 ₹45.74 67
Multiples
P/E Multiple ₹495.60 ₹660.79 ₹825.99 63
P/S Multiple ₹401.20 ₹534.93 ₹668.66 58
P/B Multiple ₹184.33 ₹245.77 ₹307.21 55
EV/EBIT ₹528.65 ₹705.57 ₹882.49 66
EV/EBITDA ₹464.33 ₹619.81 ₹775.29 67
EV/Revenue ₹376.71 ₹539.06 ₹701.41 53
Asset-Based
NCAV (Graham) ₹79.14 ₹119.90 ₹149.88 54
Growth DCF
Growth DCF ₹570.77 ₹894.11 ₹1,357 78
Rev-Margin DCF ₹456.13 ₹731.51 ₹1,083 72
Economic Profit
Residual Income ₹199.93 ₹246.52 ₹371.54 75
ROIC Compounder ₹348.25 ₹439.96 ₹552.19 72
Growth Earnings
Growth-Adj P/E ₹405.26 ₹578.95 ₹752.63 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 66/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 73
How much profit the company makes from its sales and capital
Quality Growth 35
Are margins and returns getting better?
Cashflow 68
Do the profits arrive as real cash?
Financial strength 84
Debt, balance sheet and risk of trouble
Investment 49
Does it invest with discipline instead of growing at any price?
Low Volatility 57
How calm the share price moves, does not count
Price momentum 51
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 44
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+9.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.9%
Start year 2021 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.0%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+32.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+31.7%
Dividend (yield on the price)0.7%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 7%

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.9%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about −8.6% a year for the price.

Watch PCCOSMA, get fair value alerts →

Compare PEE CEE COSMA SOPE LTD. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 241 stocks

Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 66 · Above median
Fair Value upside +41.9% · Above median
Profitability
Return on equity (12 months) 15.9% · Top 25%
Return on assets 13.1% · Top 25%
Net margin (12 months) 5.2% · Below median
Operating margin (12 months) 6.8% · Below median
Growth and dividend
Revenue growth (quarter YoY) 23.4% · Top 25%
Dividend yield (12 months) 0.7% · Bottom 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/E (12 months) 13.3× · Cheaper than median
P/B 2.06× · Pricier than median
P/S (12 months) 0.69× · Cheaper than median
Price / free cash flow (fiscal year) 8.3× · Cheapest 25%
EV/EBITDA 8.6× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)89 · sector 35
FUTURE (revenue growth)100 · sector 20
PAST (return on equity)64 · sector 29
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)14 · sector 53

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Puig Brands, S.A PUIG €19.76 €24.28 +23% vs PCCOSMA
Henkel AG HEN €78.10 €83.75 +7% vs PCCOSMA
Beiersdorf Aktiengesellschaft, BEI €79.02 €69.09 −13% vs PCCOSMA
The Clorox Company CLX $104.90 $74.29 −29% vs PCCOSMA
Godrej Consumer Products Limited GODREJCP ₹929.50 ₹657.04 −29% vs PCCOSMA
Church & Dwight Co CHD $109.68 $65.04 −41% vs PCCOSMA
Colgate-Palmolive Company CL $96.88 $56.16 −42% vs PCCOSMA
Marico Limited MARICO ₹918.80 ₹493.84 −46% vs PCCOSMA
The Estée Lauder Companies Inc EL $101.77 $44.21 −57% vs PCCOSMA
Hindustan Unilever Limited HINDUNILVR ₹2,074.20 ₹775.25 −63% vs PCCOSMA

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

PEE CEE COSMA SOPE LTD.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "PEE CEE COSMA SOPE LTD. Fair Value". https://www.fairvalue-calculator.com/stock/PCCOSMA

Frequently asked questions

Is PEE CEE COSMA SOPE LTD. (PCCOSMA) overvalued or undervalued?
As of Nov 16, 2026, our model estimates a fair value of ₹619.81 versus a price of ₹436.75, about +42% upside (undervalued).
What is the fair value of PCCOSMA?
Our model-based fair value for PEE CEE COSMA SOPE LTD. is ₹619.81 (as of Nov 16, 2026), built from audited fundamentals. The current price: ₹436.75.
What is the quality score of PCCOSMA?
PEE CEE COSMA SOPE LTD. has a Quality Score of 66/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for PEE CEE COSMA SOPE LTD. (PCCOSMA)?
We do not set a price target; the yardstick is the fair value of ₹619.81 (as of Nov 16, 2026) from 26 valuation models. Cautious scenario ₹464.33, optimistic scenario ₹775.29. It is a calculation from audited fundamentals, not an analyst target.
What is the PEE CEE COSMA SOPE LTD. stock forecast for 2026?
Our models put fair value at ₹619.81, about +42% upside versus a price of ₹436.75 (undervalued). Cautious scenario ₹464.33, optimistic scenario ₹775.29. The calculation is refreshed regularly with new filings.
What is the revenue of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
PEE CEE COSMA SOPE LTD. reported trailing-twelve-month revenue of about ₹1.7B (latest available figure, as of Nov 16, 2026).
Does PEE CEE COSMA SOPE LTD. pay a dividend?
PEE CEE COSMA SOPE LTD. currently shows a dividend yield of 0.69% relative to its recent price (as of Nov 16, 2026).
How much is the dividend of PEE CEE COSMA SOPE LTD. (PCCOSMA) and when is the ex-dividend date?
PEE CEE COSMA SOPE LTD. pays a dividend of ₹3.00 per share a year, a dividend yield of 0.7%. The last ex-dividend date was Sep 21, 2026. A dividend has been paid every year since 2013. The payout ratio is 9.1% of earnings. Free cash flow covers the dividend 17.61 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into PEE CEE COSMA SOPE LTD. (PCCOSMA)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at PEE CEE COSMA SOPE LTD. shrinks by 4.9 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 13.9 % per year. As of Nov 16, 2026.
What discount rate (WACC) does the fair value of PCCOSMA use?
Our models discount PEE CEE COSMA SOPE LTD. at 10.9 %: a base by market capitalisation (nano), damped by beta 0.24, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For PEE CEE COSMA SOPE LTD. that is -4.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has PEE CEE COSMA SOPE LTD. (PCCOSMA) delivered so far?
Over the past 5 years revenue at PEE CEE COSMA SOPE LTD. grew 13.9 % a year. The price currently implies free-cash-flow growth of -4.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of PEE CEE COSMA SOPE LTD. (PCCOSMA) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into PEE CEE COSMA SOPE LTD. (-4.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The free-cash-flow yield on the price is 12.10 %: that much free cash flow PEE CEE COSMA SOPE LTD. produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For PEE CEE COSMA SOPE LTD. it is ₹619.81 per share (as of Nov 16, 2026), against a price of ₹436.75. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is PEE CEE COSMA SOPE LTD. stock overvalued or undervalued in 2026?
As of Nov 16, 2026, PCCOSMA trades below its calculated fair value: price ₹436.75, fair value ₹619.81, a gap of about +42% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PCCOSMA?
No. The price is what the market pays today (₹436.75); the fair value is what the company's own numbers justify (₹619.81). For PEE CEE COSMA SOPE LTD. the two are ₹183.06 per share apart. That gap is exactly why we show both numbers side by side.
How much is PEE CEE COSMA SOPE LTD. worth?
The market values PEE CEE COSMA SOPE LTD. at about ₹1.2B (market capitalisation, as of Nov 16, 2026). Per share that is ₹436.75; our models calculate a fair value of ₹619.81 per share.
What do the bullish and bearish scenarios say about PCCOSMA?
Our models span a range for PEE CEE COSMA SOPE LTD.: cautious scenario ₹464.33, base ₹619.81, optimistic ₹775.29 per share (as of Nov 16, 2026, price ₹436.75). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PCCOSMA?
PEE CEE COSMA SOPE LTD. trades at a price-to-earnings ratio of 13.3 (as of Nov 16, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹619.81 is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2019 to 2026), reported earnings: 9.7. Other multiples: P/B 2.1, P/S 0.7, EV/EBITDA 8.6.
How solid is the balance sheet of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
Balance-sheet figures for PEE CEE COSMA SOPE LTD. (as of Nov 16, 2026): return on equity 15.9%. They feed the Quality Score of 66/100, which measures business quality independently of the share price.
How far is PCCOSMA from its 52-week high?
PEE CEE COSMA SOPE LTD. trades at ₹436.75, about 13% below its 52-week high of ₹501.50 and 49% above the low of ₹292.55 (as of Nov 19, 2026). Distance from the high says nothing about value: that is what the fair value of ₹619.81 is for.
Which stocks are comparable to PEE CEE COSMA SOPE LTD.?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, The Estée Lauder Companies Inc, Henkel AG, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is PEE CEE COSMA SOPE LTD. stock attractive at the current price?
The data as of Nov 16, 2026: price ₹436.75, calculated fair value ₹619.81 (+42%), Quality Score 66/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PCCOSMA calculated?
We run PEE CEE COSMA SOPE LTD. through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹619.81 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 11.0% above its aggregate fair value. PEE CEE COSMA SOPE LTD. currently trades 30% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The closing price on Nov 19, 2026 was ₹436.75. Our model-based fair value is ₹619.81, about +42% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with PEE CEE COSMA SOPE LTD. right now?
The price is below even our cautious bear case (₹464.33). The market is more pessimistic than our downside scenario. Solid quality (66/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of PEE CEE COSMA SOPE LTD.

How large is the market capitalisation of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The market capitalisation of PEE CEE COSMA SOPE LTD. is ₹1.2B (≈ $12.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The price-to-sales ratio of PEE CEE COSMA SOPE LTD. is 0.69 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
Earnings per share at PEE CEE COSMA SOPE LTD. are ₹32.80 (price ÷ EPS = P/E 13.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The dividend yield of PEE CEE COSMA SOPE LTD. is 0.7% (payout 9.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The net margin of PEE CEE COSMA SOPE LTD. is 5.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The return on equity (ROE) of PEE CEE COSMA SOPE LTD. is 15.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
On an EBIT basis the return on assets of PEE CEE COSMA SOPE LTD. is 15.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of PEE CEE COSMA SOPE LTD. (PCCOSMA)?
The operating margin of PEE CEE COSMA SOPE LTD. is 6.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at PEE CEE COSMA SOPE LTD. (PCCOSMA)?
Revenue at PEE CEE COSMA SOPE LTD. is growing 23.4% versus a year earlier (3y avg +8.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at PEE CEE COSMA SOPE LTD. (PCCOSMA)?
Earnings per share at PEE CEE COSMA SOPE LTD. are growing 11.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does PEE CEE COSMA SOPE LTD. (PCCOSMA) carry?
The net debt of PEE CEE COSMA SOPE LTD. is ₹5.6M (fiscal year 2025, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch PEE CEE COSMA SOPE LTD. in the live analysis

One click puts PEE CEE COSMA SOPE LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.